170 related articles for article (PubMed ID: 5909697)
1. Differential ferrioxamine test in idiopathic haemochromatosis and transfusional haemosiderosis.
Fielding J; O'Shaughnessy MC; Brunström GM
J Clin Pathol; 1966 Mar; 19(2):159-64. PubMed ID: 5909697
[TBL] [Abstract][Full Text] [Related]
2. Differential ferrioxamine test in haemochromatosis and liver diseases.
Barry M; Cartei G; Sherlock S
Gut; 1969 Sep; 10(9):697-704. PubMed ID: 5386626
[TBL] [Abstract][Full Text] [Related]
3. Sideruria following a single dose of desferrioxamine-B as a diagnostic test in iron overload.
Ploem JE; de Wael J; Verloop MC; Punt K
Br J Haematol; 1966 Jul; 12(4):396-408. PubMed ID: 5944488
[No Abstract] [Full Text] [Related]
4. DIFFERENTIAL FERRIOXAMINE TEST FOR MEASURING CHELATABLE BODY IRON.
FIELDING J
J Clin Pathol; 1965 Jan; 18(1):88-97. PubMed ID: 14247711
[TBL] [Abstract][Full Text] [Related]
5. Assessment of body-iron stores in cirrhosis and haemochromatosis with the differential ferrioxamine test.
Smith PM; Studley F; Williams R
Lancet; 1967 Jan; 1(7482):133-6. PubMed ID: 4163312
[No Abstract] [Full Text] [Related]
6. Confirmation of the efficacy of hepatic tissue iron index in differentiating genetic haemochromatosis from alcoholic liver disease complicated by alcoholic haemosiderosis.
Sallie RW; Reed WD; Shilkin KB
Gut; 1991 Feb; 32(2):207-10. PubMed ID: 1864543
[TBL] [Abstract][Full Text] [Related]
7. Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy.
McLaren GD; Muir WA; Kellermeyer RW
Crit Rev Clin Lab Sci; 1983; 19(3):205-66. PubMed ID: 6373141
[TBL] [Abstract][Full Text] [Related]
8. THE TREATMENT OF HAEMOCHROMATOSIS WITH DESFERRIOXAMINE.
WOEHLER F
Acta Haematol; 1963 Aug; 30():65-87. PubMed ID: 14064792
[No Abstract] [Full Text] [Related]
9. Iron storage in relatives of patients with haemochromatosis and in relatives of patients with alcoholic cirrhosis and haemosiderosis. A comparative study of 27 families.
Powell LW
Q J Med; 1965 Oct; 34(136):427-42. PubMed ID: 5862745
[No Abstract] [Full Text] [Related]
10. The differential ferrioxamine test in the management of idiopathic haemochromatosis.
Smith PM; Lestas AN; Miller JP; Dymock IW; Pitcher CS; Williams R
Lancet; 1969 Aug; 2(7617):402-5. PubMed ID: 4184489
[No Abstract] [Full Text] [Related]
11. Pharmacokinetics of aluminoxamine and ferrioxamine and dose finding of desferrioxamine in haemodialysis patients.
Verpooten GA; D'Haese PC; Boelaert JR; Becaus I; Lamberts LV; De Broe ME
Nephrol Dial Transplant; 1992; 7(9):931-8. PubMed ID: 1328941
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis of iron overload and hemochromatosis (author's transl)].
Niederau C; Strohmeyer G
Leber Magen Darm; 1981 Apr; 11(2):56-62. PubMed ID: 7015044
[TBL] [Abstract][Full Text] [Related]
13. DESFERRIOXAMINE EFFECT ON IRON EXCRETION IN HEMOCHROMATOSIS.
WALSH JR; MASS RE; SMITH FW; LANGE V
Arch Intern Med; 1964 Mar; 113():435-41. PubMed ID: 14096399
[No Abstract] [Full Text] [Related]
14. Erythrocyte ferritin content in idiopathic haemochromatosis and alcoholic liver disease with iron overload.
Van Der Weyden MB; Fong H; Salem HH; Batey RG; Dudley FJ
Br Med J (Clin Res Ed); 1983 Mar; 286(6367):752-4. PubMed ID: 6402233
[TBL] [Abstract][Full Text] [Related]
15. Heredity of idiopathic haemochromatosis: a study of 106 families.
Simon M; Alexandre JL; Bourel M; Le Marec B; Scordia C
Clin Genet; 1977 May; 11(5):327-41. PubMed ID: 862210
[TBL] [Abstract][Full Text] [Related]
16. [RESEARCH ON DESFERRIOXAMINE B. 3. THE CLINICAL USE OF DESFERRIOXAMINE B].
VENTURA S; COLI L
Haematologica; 1964; 49():252-73. PubMed ID: 14217827
[No Abstract] [Full Text] [Related]
17. Current concepts in rational therapy for haemochromatosis.
Crawford DH; Halliday JW
Drugs; 1991 Jun; 41(6):875-82. PubMed ID: 1715264
[TBL] [Abstract][Full Text] [Related]
18. Long term results of venesection therapy in idiopathic haemochromatosis.
Bomford A; Williams R
Q J Med; 1976 Oct; 45(180):611-23. PubMed ID: 188063
[TBL] [Abstract][Full Text] [Related]
19. Serum increase and liver overexpression of carbohydrate 19.9 antigen in patients with genetic haemochromatosis.
Deugnier YM; Rabot AF; Guyader D; Moirand R; Turlin B; Boucher E; Lebert P; Brissot P
Gut; 1994 Aug; 35(8):1107-11. PubMed ID: 7926915
[TBL] [Abstract][Full Text] [Related]
20. Deferoxamine-chelatable iron in hemochromatosis and other disorders of iron overload.
Baldus WP; Fairbanks VF; Dickson ER; Baggenstoss AH
Mayo Clin Proc; 1978 Mar; 53(3):157-65. PubMed ID: 628226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
